Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
About Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Alkahest, Inc.
1
Clinical Trials at Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
During the past decade, Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment
2020-01-16
2021-03-10
Completed
110
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
2020-12-03
2029-09-06
Recruiting
699
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
2021-03-24
2025-11-27
Recruiting
736
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
According to Clinical.Site data, the most researched conditions in "Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych" are
"Alzheimer Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych" in a lesser frequency.
Clinical Trials Intervention Types at Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
Most popular intervention types in "Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Placebo" (3 trials), "Antihistamine" (2 trials), "Gantenerumab" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
The vast majority of trials in "Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych" are
7 trials for "All" genders.
Clinical Trials Status at Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
Currently, there are NaN active trials in "Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych
Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych has several departments that took part in Clinical trials: "Neurologiczny NZOZ Centrum Leczenia SM Osrodek Badan Klinicznych Dr n med Hanka Hertmanowska" - 5 trials, "Neurologiczny NZOZ Centrum Leczenia SM" - 2 trials
Departments List